Eli Lilly to Acquire Dice Therapeutics in Deal Valued at $2.4 Billion
- June 23, 2023
Eli Lilly & Co. would acquire biopharmaceutical firm Dice Therapeutics for roughly $2.4 billion under a definite merger agreement announced June 20.
ARTICLE TAGS
You must be logged in to access this content.